Literature DB >> 22644800

When a reference value makes all the difference.

Wolfram Doehner1.   

Abstract

Entities:  

Year:  2012        PMID: 22644800      PMCID: PMC3374021          DOI: 10.1007/s13539-012-0076-4

Source DB:  PubMed          Journal:  J Cachexia Sarcopenia Muscle        ISSN: 2190-5991            Impact factor:   12.910


× No keyword cloud information.
Dear Editor, I read with great interest the article by Webber and Barr on the age- and gender-dependent values of skeletal muscle mass in healthy children and adolescents [1]. The authors open a field of scientific dispute that is often underrepresented if not totally neglected. The validity of any method of measurement depends not only on the appropriate choice of a certain method according to the question to be studied. In fact, the interpretation of the results depends just as much on the existence of adequate standards and reference values to which our measurements can be compared. Age and gender are fundamental factors influencing probably all biological measurements and should be taken into account for correct interpretation of clinical data. Webber and Barr provide reference values for normal ranges of skeletal muscle tissue mass in children and adolescents separately for females and males. Moreover, they confirm the high reproducibility of dual X-ray absorptiometry (DXA) to detect differences in muscle tissue mass as low as a few hundred grams. For this rather sophisticated method of assessing body composition, interpretation according to age and gender seems well appreciated. By contrast, it is surprising that the most global measure of body composition, namely body mass index (BMI), is commonly applied to patients and populations irrespective of age. There is increasing evidence that in older populations the association of body composition with mortality is substantially shifted as compared to middle-aged populations [2-4]. According to the World Health Organisation, the “optimum BMI” ranges from 18.5 to 25 kg/m2. It may be another point of discussion what the “optimum” refers to and whether these margins are still applicable, as the nadir of the mortality curves in recent epidemiological observations is around or even above 25 kg/m2 [4]. The discussion on the accuracy of BMI as a predictor of disease and/or mortality is ongoing [5]. Clearly, the simplicity of the method may be weighed against the limitations of the data obtained. A first step would be to address different age groups for reference values of BMI, just as presented by Webber and Barr for DXA.
  6 in total

1.  Height, weight and mortality. The Norwegian experience.

Authors:  H T Waaler
Journal:  Acta Med Scand Suppl       Date:  1984

2.  Excess deaths associated with underweight, overweight, and obesity.

Authors:  Katherine M Flegal; Barry I Graubard; David F Williamson; Mitchell H Gail
Journal:  JAMA       Date:  2005-04-20       Impact factor: 56.272

3.  Age- and gender-dependent values of skeletal muscle mass in healthy children and adolescents.

Authors:  Colin E Webber; Ronald D Barr
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-10-30       Impact factor: 12.910

4.  Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old.

Authors:  Kenneth F Adams; Arthur Schatzkin; Tamara B Harris; Victor Kipnis; Traci Mouw; Rachel Ballard-Barbash; Albert Hollenbeck; Michael F Leitzmann
Journal:  N Engl J Med       Date:  2006-08-22       Impact factor: 91.245

5.  Accuracy of body mass index in diagnosing obesity in the adult general population.

Authors:  A Romero-Corral; V K Somers; J Sierra-Johnson; R J Thomas; M L Collazo-Clavell; J Korinek; T G Allison; J A Batsis; F H Sert-Kuniyoshi; F Lopez-Jimenez
Journal:  Int J Obes (Lond)       Date:  2008-02-19       Impact factor: 5.095

6.  Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle.

Authors:  Stephan von Haehling; John E Morley; Andrew J S Coats; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-10-26       Impact factor: 12.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.